Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer claims novel p38 MAP kinase inhibitors in a recent patent

June 1, 2004

Roche researchers describe 5-HT receptor ligands for psychoses, dementia, etc.

June 1, 2004

New aminopeptidase N inhibitors and their use in atherosclerosis and other disorders

June 1, 2004

Novel beta2-adrenoceptor agonists discovered at Boehringer Ingelheim

June 1, 2004

Dual PDE3/L-type Ca2+ channel inhibitors covered by Artesian patent

June 1, 2004

Encore claims esters of R-NSAIDs and their therapeutic use

June 1, 2004

Two series of MMP, TACE and/or aggrecanase inhibitors presented by BMS

June 1, 2004

UCB to acquire Celltech

June 1, 2004

Zemplar approved for pediatric use

June 1, 2004

Atiprimod enters new phase I/II trial in relapsed multiple myeloma

June 1, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...